| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/070674370905400507 |
| P698 | PubMed publication ID | 19497165 |
| P2093 | author name string | Lakshmi N Ravindran | |
| Margaret A Richter | |||
| Arun V Ravindran | |||
| Neil A Rector | |||
| Tricia L da Silva | |||
| P2860 | cites work | Psychotherapies for hypochondriasis | Q24245807 |
| Do coping skills mediate the relationship between cognitive-behavioral therapy and reductions in gambling in pathological gamblers? | Q28236151 | ||
| An outcome study of Gamblers Anonymous | Q28291926 | ||
| The potential role of haloperidol in the treatment of trichotillomania | Q33853758 | ||
| Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling | Q44351769 | ||
| Treatment of trichotillomania with behavioral therapy or fluoxetine: a randomized, waiting-list controlled study. | Q44438421 | ||
| An open-label trial of bupropion in the treatment of pathologic gambling | Q44717931 | ||
| Escitalopram for compulsive buying disorder: a double-blind discontinuation study | Q45194160 | ||
| Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study | Q45265367 | ||
| Sustained-release bupropion versus naltrexone in the treatment of pathological gambling: a preliminary blind-rater study | Q46800105 | ||
| Group therapy for pathological gamblers: a cognitive approach | Q47956191 | ||
| N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study | Q48196146 | ||
| The efficacy of cognitive-behavioral therapy and the problem of drop-out | Q48403921 | ||
| Retaining pathological gamblers in cognitive behavior therapy through motivational enhancement: A pilot study | Q48452530 | ||
| Brief motivational treatment for problem gambling: a 24-month follow-up | Q48518746 | ||
| An open naltrexone treatment study in pathological gambling disorder | Q48664762 | ||
| Altered dopamine function in pathological gambling | Q48764278 | ||
| Pathological gambling among high school students | Q48968313 | ||
| The treatment of compulsive gambling | Q49161786 | ||
| Open-label escitalopram treatment for pathological skin picking. | Q50891884 | ||
| A comparison of individual and group cognitive-behavioural treatment for female pathological gambling. | Q51772037 | ||
| Treatment of female pathological gambling: the efficacy of a cognitive-behavioural approach. | Q51789837 | ||
| Escitalopram treatment of trichotillomania. | Q51909094 | ||
| A community-based psychoeducational group approach to hypochondriasis. | Q51952454 | ||
| Body dysmorphic disorder in psychiatric outpatients: recognition, prevalence, comorbidity, demographic, and clinical correlates. | Q51990668 | ||
| Habit reversal as a treatment for chronic skin picking: a pilot investigation. | Q52016880 | ||
| A double-blind comparison of clomipramine and desipramine treatment of severe onychophagia (nail biting). | Q52048738 | ||
| Evaluation of patients treated for pathological gambling in a combined alcohol, substance abuse and pathological gambling treatment unit using the Addiction Severity Index. | Q52265742 | ||
| Citalopram Treatment of Compulsive Shopping | Q57381711 | ||
| Placebo-Controlled Study of Fluvoxamine in the Treatment of Patients With Compulsive Buying | Q57616596 | ||
| Body dysmorphic disorder: A cognitive behavioural model and pilot randomised controlled trial | Q57872807 | ||
| Body Dysmorphic Disorder | Q57872821 | ||
| Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness | Q33880704 | ||
| Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling | Q33948583 | ||
| An open trial of fluvoxamine for hypochondriasis | Q33966848 | ||
| Cognitive behavior therapy for hypochondriasis: a randomized controlled trial | Q33976857 | ||
| A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder | Q33994634 | ||
| Cognitive behavior therapy and paroxetine in the treatment of hypochondriasis: a randomized controlled trial | Q34001744 | ||
| Behavioral, cognitive, and family therapy for obsessive-compulsive and related disorders | Q34032787 | ||
| Two psychological treatments for hypochondriasis. A randomised controlled trial | Q34068401 | ||
| Kleptomania: a report of 20 cases | Q34100422 | ||
| A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling | Q34135868 | ||
| Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? | Q34380515 | ||
| Pathological gambling. A psychobiological study | Q34403473 | ||
| Chronic nailbiting: a controlled comparison of competing response and mild aversion treatments | Q34403768 | ||
| Fluvoxamine in the treatment of compulsive buying | Q34427139 | ||
| A controlled evaluation of acceptance and commitment therapy plus habit reversal for trichotillomania | Q34436284 | ||
| A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder | Q34522077 | ||
| A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling) | Q34540004 | ||
| Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study | Q34616679 | ||
| A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania | Q34962280 | ||
| Change in psychosocial functioning and quality of life of patients with body dysmorphic disorder treated with fluoxetine: a placebo-controlled study | Q35095094 | ||
| An open-label study of escitalopram in body dysmorphic disorder | Q35095202 | ||
| Pharmacotherapy for body dysmorphic disorder: treatment received and illness severity | Q35568961 | ||
| Do antipsychotics ameliorate or exacerbate Obsessive Compulsive Disorder symptoms? A systematic review | Q35920009 | ||
| Outcome study of kleptomania patients treated with naltrexone: a chart review | Q36042224 | ||
| Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies | Q36161335 | ||
| Psychological treatment dropout among pathological gamblers | Q36791424 | ||
| Outcome of pharmacological treatments of pathological gambling: a review and meta-analysis | Q36882312 | ||
| Systematic review: pharmacological and behavioral treatment for trichotillomania | Q36922622 | ||
| Treating nailbiting: a comparative analysis of mild aversion and competing response therapies | Q38514416 | ||
| Controlled Comparison of Aversive Therapy and Imaginal Desensitization in Compulsive Gambling | Q39559941 | ||
| Group treatment for trichotillomania: behavior therapy versus supportive therapy | Q40274888 | ||
| Topiramate in the treatment of trichotillomania: an open-label pilot study | Q40302302 | ||
| Psychiatric comorbidity in pathological gambling: a critical review | Q40867539 | ||
| Are impulse-control disorders related to bipolar disorder? | Q41127483 | ||
| An open clinical trial of fluvoxamine treatment of psychogenic excoriation | Q42691646 | ||
| Psychiatric comorbidity in DSM-III-R hypochondriasis | Q43490179 | ||
| Fluoxetine in pathologic skin-picking: open-label and double-blind results | Q43701772 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 331-343 | |
| P577 | publication date | 2009-05-01 | |
| P1433 | published in | Canadian Journal of Psychiatry | Q5030253 |
| P1476 | title | Obsessive-compulsive spectrum disorders: a review of the evidence-based treatments | |
| P478 | volume | 54 |
| Q24611363 | Cognitive-behavioral therapy for body dysmorphic disorder: a review of its efficacy |
| Q34299932 | Correlates of obsessive-compulsive disorder in a sample of HIV-positive, methamphetamine-using men who have sex with men. |
| Q60637044 | Die Bedeutung von Ekel- und Angstsensitivität bei Personen mit der Verdachtsdiagnose einer Hypochondrie |
| Q48672925 | Plea to establish a registry of clinical trials on cognitive-behavioural therapies and cognitive remediation |
| Q47211496 | Psychopharmacology Utilization Among Children with Anxiety and Obsessive-Compulsive and Related Disorders Following Hurricane Katrina |
| Q37700925 | Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V? |
| Q41894499 | The emergence of obsessive compulsive and compulsive buying symptomatology after acute stress and short-term use of ribavirin: case reports |
| Q61904867 | Zwangs- und verwandte Störungen im Licht der neuen DSM-5 Kriterien |
Search more.